Frontlight ResearchEarly access
Trial site
Macquarie University Hospital
- 8running trials
- 2closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Bladder cancer3 trials
- Prostate cancer3 trials
- Chronic lymphocytic leukaemia2 trials
- Hodgkin lymphoma2 trials
- Acute myeloid leukaemia1 trial
- Alzheimer disease1 trial
- Chronic myeloid leukaemia1 trial
- Endometrial cancer1 trial
- Head and neck cancer1 trial
- Lung cancer1 trial
- Multiple myeloma1 trial
- Myelodysplastic syndromes1 trial
- and 1 more
- Phase
- Phase 36 trials
- Phase 13 trials
- Phase 21 trial
- Status
- Active, not recruiting5 trials
- Completed2 trials
- Recruiting2 trials
- Enrolling by invitation1 trial
- Lead sponsor
- Janssen Research & Development, LLC5 trials
- Hoffmann-La Roche2 trials
- Seagen, a wholly owned subsidiary of Pfizer2 trials
- Eli Lilly and Company1 trial
Running trials
Recruiting
Recruiting
A Study of LY3439539 in Participants With Alzheimer's Disease
Enrolling by invitation
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Active, not recruiting
A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
Active, not recruiting
Active, not recruiting
A Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPC
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Alzheimer disease1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Hodgkin lymphoma1 recruiting
- Multiple myeloma1 recruiting
- Myelodysplastic syndromes1 recruiting
- Prostate cancer1 recruiting
Closed trials
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026